financetom
Business
financetom
/
Business
/
Curanex Pharmaceuticals Prices $15 Million Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Curanex Pharmaceuticals Prices $15 Million Initial Public Offering
Aug 26, 2025 5:20 AM

07:55 AM EDT, 08/26/2025 (MT Newswires) -- Curanex Pharmaceuticals (CURX) said Tuesday it priced its initial public offering of 3.75 million common shares at $4 each, for gross proceeds of $15 million.

IPO underwriters have a 45-day overallotment option to acquire up to 562,500 additional shares.

The developmental-stage pharmaceutical company said it expects its shares to start trading on the Nasdaq Capital Market under the ticker symbol CURX Tuesday.

It expects the IPO to close Wednesday and plans to use the proceeds for the development of its lead product candidate, Phyto-N, to treat ulcerative colitis, among other things.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved